1. "2010"
Formats
  1. Journal Article (2028)
  2. Meeting Abstract (717)
  3. Book Section (199)
  4. Book Whole (15)
  5. Conference Paper (10)
Groups
  1. Department of Medicine (846)
  2. Surgery (812)
  3. GSK Faculty (604)
  4. Sloan Kettering Institute Faculty (501)
  5. Solid Tumor Oncology Division (494)
  6. Survivorship Research (462)

More Groups

People
  1. Richard Barakat (59)
  2. Dennis Chi (58)
  3. Victor Reuter (57)
  4. Nadeem Abu-Rustum (53)
  5. Peter Scardino (49)
  6. Robert Soslow (49)

More People

Years
  1. 2010 (2969)
Publications
  1. Journal of Clinical Oncology (283)
  2. Cancer Research (79)
  3. Blood (78)
  4. International Journal of Radiation Oncology, Biology, Physics (78)
  5. Modern Pathology (72)
  6. Gynecologic Oncology (67)

More Publications

Publishers
  1. Elsevier Inc. (383)
  2. American Society of Clinical Oncology (284)
  3. Elsevier Science, Inc. (183)
  4. Springer (177)
  5. Lippincott Williams & Wilkins (153)
  6. Nature Publishing Group (144)

More Publishers

Results (2969)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Late recurring uterine smooth muscle tumors constitute a heterogeneous collection of leiomyosarcomas and STUMPs
    Meeting Abstract

    Veras, E.; Zivanovic, O.; Jacks, L.; Hensley, M.; Soslow, R.
    Laboratory Investigation (2010)

    Fulltext@MSK | Save
  • Involvement of the VHL pathway in the pathogenesis of sporadic pancreatic endocrine neoplasms
    Meeting Abstract

    Veras, E.; Tang, L.; Klimstra, D.
    Laboratory Investigation (2010)

    Fulltext@MSK | Save
  • NK cell killer Ig-like receptor (KIR) genotype as a novel biomarker for neuroblastoma patients receiving anti-GD2 monoclonal antibody 3F8
    Meeting Abstract

    Venstrom, J. M.; Zheng, J.; Kushner, B. H.; Modak, S.; Danis, K. E.; Cheung, I. Y.; Dupont, B.; Cheung, N. K.; Hsu, K. C.
    Cancer Research (2010)

    Fulltext@MSK | Save
  • Identification of DNA ligase IV inhibitors as possible drug and probe candidates for enhancement of radiation treatment and chemotherapy
    Meeting Abstract

    Tseng, H. M.; Shum, D.; Djaballah, H.; Scheinberg, D.
    Cancer Research (2010)

    Fulltext@MSK | Save
  • Dual fluorescence high throughput screen detects MUC16 selective therapeutic candidates
    Meeting Abstract

    Thapi, D.; Normand, G.; Ivnitski Steele, I. D.; Ostrovnaya, I.; Shum, D.; Spriggs, D. R.; Djaballah, H.
    Cancer Research (2010)

    Fulltext@MSK | Save
  • Clinical activity of DNA methyltransferase inhibitors in therapy-related myelodysplastic syndromes: A retrospective study
    Meeting Abstract

    Tees, M. T.; Dolezal, E. K.; Nimer, S. D.; Klimek, V. M.
    Blood (2010)

    Fulltext@MSK | Save
  • Grade progression of well differentiated neuroendocrine tumors (WDNETs) of the enteropancreatic system is distinct from poorly differentiated (PD) high grade neuroendocrine carcinomas (PDHGNECas)
    Meeting Abstract

    Tang, L. H.; Song, L.; Shia, J.; Vakiani, E.; Klimstra, D. S.
    Laboratory Investigation (2010)

    Fulltext@MSK | Save
  • Transformation of appendiceal goblet cell carcinoid tumor to adenocarcinoma is correlated with the status of KRAS mutation
    Meeting Abstract

    Tang, L. H.; Lau, C.; Schoepflin, A.; Shia, J.; Lassmann, S.; Ladanyi, M.; Werner, M.; Klimstra, D. S.
    Laboratory Investigation (2010)

    Fulltext@MSK | Save
  • HER2 status in gastric cancer: Correlation between IHC and FISH
    Meeting Abstract

    Tafe, L. J.; Zaidinski, M.; Hedvat, C.; Tang, L.; Janjigian, Y.; Shah, M.; Barbashina, V.
    Laboratory Investigation (2010)

    Fulltext@MSK | Save
  • Automated bright-field dual color, dual hapten HER2 in situ hybridization (DISH) assay: An alternative method for evaluation of HER2 gene amplification in breast cancer
    Meeting Abstract

    Tafe, L. J.; Teruya-Feldstein, J.; McElhinny, A.; Ranger-Moore, J.; Emch, J.; Schemp, C.; Barbashina, V.
    Modern Pathology (2010)

    Fulltext@MSK | Save